Gene patents —a time to balance access and incentives

The issue of patents on inventions of genomic research is the subject of intense debate. The exchange of scientific information and access to new technologies are critical to biomedical research. Similarly, strong patent laws are necessary to encourage innovation. Thus, it is time to balance access...

Full description

Saved in:
Bibliographic Details
Published inTrends in biotechnology (Regular ed.) Vol. 14; no. 8; pp. 298 - 302
Main Author Thomas Caskey, C.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.08.1996
Subjects
Biotechnology - legislation & jurisprudence
Biotechnology - trends
Computational Biology - trends
Genome
Government
History, 20th Century
Human Genome Project - history
Humans
Industry
Patents as Topic - history
United States
United States
Online AccessGet full text

Cover

More Information
Summary:The issue of patents on inventions of genomic research is the subject of intense debate. The exchange of scientific information and access to new technologies are critical to biomedical research. Similarly, strong patent laws are necessary to encourage innovation. Thus, it is time to balance access and incentive. Patents claiming genes with purely speculative utilities should not be issued, and they possibly limit research. Reasonable access to properly patented genes should be provided for research, and exclusive positions maintained for commercial utilities. This will promote ready access to genomic information and fundamental technologies, while optimizing the discovery and disclosure of basic advances in biomedical research.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0167-7799
1879-3096
DOI:10.1016/0167-7799(96)10039-1